All Research Papers Published In EJC Supplements

Research Article
10.1016/j.ejcsup.2025.12.002

Isocitrate dehydrogenase mutations as potential tumour agnostic targets☆

Mar 01, 2026
EJC Supplements
Teresa Macarulla + 3 more +3

Front Matter
10.1016/j.ejcsup.2021.06.001

Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?

Nov 01, 2021
EJC Supplements
Martyn E Caplin

Abstract
10.1016/j.ejcsup.2015.08.127

A60: Signs of cell–cell interactions and ultrastructural changes in the tumor under the effective impact of the weak microwave radiation on the central nervous system and peritumoral zone in the experiment

Nov 01, 2015
EJC Supplements
G Zhukova + 6 more +6

Abstract
10.1016/j.ejcsup.2015.08.052

P41: Role of the optical methods for blood study in staging of colorectal cancer

Nov 01, 2015
EJC Supplements
M Kruchinina + 9 more +9

Abstract
10.1016/j.ejcsup.2015.08.003

T117: The plasticity of tumor cell migration mechanism is adaptive factor increasing metastasis efficiency

Nov 01, 2015
EJC Supplements
A Alexandrova + 1 more +1

Abstract
2
10.1016/j.ejcsup.2015.08.106

P39: Blood cell-surface-bound exosomes as a new source of tumor-specific microRNA

Nov 01, 2015
EJC Supplements
S Tamkovich + 9 more +9

Abstract
10.1016/j.ejcsup.2015.08.117

A36: The TP53 mutations in the Russian patients with de novo DLBCL

Nov 01, 2015
EJC Supplements
E Voropaeva + 3 more +3

Abstract
10.1016/j.ejcsup.2015.08.034

P20: Does LMP1 oncogene expression pattern reflect specific pathology or geographic origin of the EPSTEIN–BARR virus?

Nov 01, 2015
EJC Supplements
V Gurtsevitch + 5 more +5

Abstract
10.1016/j.ejcsup.2015.08.064

P123: Evolutionary novel genes expressed in fish tumors determine progressive evolutionary characters

Nov 01, 2015
EJC Supplements
E Matiunina + 2 more +2

Abstract
10.1016/j.ejcsup.2015.08.009

P113: The protective effect of G1958A SNP on the MTHFD1 gene in susceptibility to non-Hodgkin malignant lymphomas

Nov 01, 2015
EJC Supplements
O Berezina + 4 more +4